166 related articles for article (PubMed ID: 16085540)
1. Gene expression profiling in the myelodysplastic syndromes.
Pellagatti A; Fidler C; Wainscoat JS; Boultwood J
Hematology; 2005 Aug; 10(4):281-7. PubMed ID: 16085540
[TBL] [Abstract][Full Text] [Related]
2. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.
Roela RA; Carraro DM; Brentani HP; Kaiano JH; Simão DF; Guarnieiro R; Lopes LF; Borojevic R; Brentani MM
Leuk Res; 2007 May; 31(5):579-89. PubMed ID: 17092558
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression.
Borojevic R; Roela RA; Rodarte RS; Thiago LS; Pasini FS; Conti FM; Rossi MI; Reis LF; Lopes LF; Brentani MM
Leuk Res; 2004 Aug; 28(8):831-44. PubMed ID: 15203281
[TBL] [Abstract][Full Text] [Related]
4. Biology of the bone marrow microenvironment and myelodysplastic syndromes.
Rankin EB; Narla A; Park JK; Lin S; Sakamoto KM
Mol Genet Metab; 2015; 116(1-2):24-8. PubMed ID: 26210353
[TBL] [Abstract][Full Text] [Related]
5. Detection of an activated JAK3 variant and a Xq26.3 microdeletion causing loss of PHF6 and miR-424 expression in myelodysplastic syndromes by combined targeted next generation sequencing and SNP array analysis.
Kunze K; Gamerdinger U; Leßig-Owlanj J; Sorokina M; Brobeil A; Tur MK; Blau W; Burchardt A; Käbisch A; Schliesser G; Kiehl M; Rosenwald A; Rummel M; Grimminger F; Hain T; Chakraborty T; Bräuninger A; Gattenlöhner S
Pathol Res Pract; 2014 Jun; 210(6):369-76. PubMed ID: 24674452
[TBL] [Abstract][Full Text] [Related]
6. Hematopoiesis-related microRNA expression in myelodysplastic syndromes.
Pons A; Nomdedeu B; Navarro A; Gaya A; Gel B; Diaz T; Valera S; Rozman M; Belkaid M; Montserrat E; Monzo M
Leuk Lymphoma; 2009 Nov; 50(11):1854-9. PubMed ID: 19883312
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology.
Pellagatti A; Esoof N; Watkins F; Langford CF; Vetrie D; Campbell LJ; Fidler C; Cavenagh JD; Eagleton H; Gordon P; Woodcock B; Pushkaran B; Kwan M; Wainscoat JS; Boultwood J
Br J Haematol; 2004 Jun; 125(5):576-83. PubMed ID: 15147372
[TBL] [Abstract][Full Text] [Related]
8. DNA micro-array analysis of myelodysplastic syndrome.
Mano H
Leuk Lymphoma; 2006 Jan; 47(1):9-14. PubMed ID: 16321821
[TBL] [Abstract][Full Text] [Related]
9. Uncoding the genetic heterogeneity of myelodysplastic syndrome.
Lindsley RC
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):447-452. PubMed ID: 29222292
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome.
Qian J; Chen Z; Wang W; Cen J; Xue Y
Oncol Rep; 2005 Nov; 14(5):1189-97. PubMed ID: 16211284
[TBL] [Abstract][Full Text] [Related]
11. [Advances of study on immunophenotyping of myelodysplastic syndromes-review].
Qiao C; Fan L; Wu YJ; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1106-10. PubMed ID: 19698271
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow niche in the myelodysplastic syndromes.
Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
[TBL] [Abstract][Full Text] [Related]
13. [Transcriptome profiling of marrow mononuclear cells of patients with myelodysplastic syndrome using cDNA microarray analysis].
Qian J; Chen ZX; Wang W; Cen JN; Xue YQ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1260-4. PubMed ID: 15387962
[TBL] [Abstract][Full Text] [Related]
14. Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes.
Kuang X; Chi J; Wang L
Hematology; 2016 Dec; 21(10):593-602. PubMed ID: 27357100
[TBL] [Abstract][Full Text] [Related]
15. Identification of defects in the transcriptional program during lineage-specific in vitro differentiation of CD34(+) cells selected from patients with both low- and high-risk myelodysplastic syndrome.
Gueller S; Komor M; Nowak D; Baldus CD; de Vos S; Hoelzer D; Ottmann OG; Hofmann WK
Exp Hematol; 2010 Sep; 38(9):718-32, 732.e1-6. PubMed ID: 20621626
[TBL] [Abstract][Full Text] [Related]
16. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow.
Hofmann WK; de Vos S; Komor M; Hoelzer D; Wachsman W; Koeffler HP
Blood; 2002 Nov; 100(10):3553-60. PubMed ID: 12411319
[TBL] [Abstract][Full Text] [Related]
17. [Myelodysplastic syndromes: preleukemic syndromes].
Tassin F; Hermanne JP; Schaaf-Lafontaine N; Herens C; Thiry A; Paulus JM; Boniver J; Fillet G
Rev Med Liege; 1998 Jun; 53(6):357-62. PubMed ID: 9713217
[TBL] [Abstract][Full Text] [Related]
18. GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.
Guerenne L; Beurlet S; Said M; Gorombei P; Le Pogam C; Guidez F; de la Grange P; Omidvar N; Vanneaux V; Mills K; Mufti GJ; Sarda-Mantel L; Noguera ME; Pla M; Fenaux P; Padua RA; Chomienne C; Krief P
J Hematol Oncol; 2016 Jan; 9():5. PubMed ID: 26817437
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview.
Jhanwar SC
Adv Biol Regul; 2015 May; 58():28-37. PubMed ID: 25499150
[TBL] [Abstract][Full Text] [Related]
20. The molecular basis of myelodysplastic syndromes.
Gallagher A; Darley RL; Padua R
Haematologica; 1997; 82(2):191-204. PubMed ID: 9175327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]